Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion type Assertion NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_head.
- NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion description "[Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_provenance.
- NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion evidence source_evidence_curated NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_provenance.
- NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion SIO_000772 19636011 NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_provenance.
- NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion wasDerivedFrom ctd_human-20150221 NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_provenance.
- NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_assertion wasGeneratedBy ECO_0000218 NP31928.RAWHE7j9kESrwkthE4LRMnUHpJlbMpQy-ufpWRuPSnppU130_provenance.